hero-line-left hero-line-top
For Health Systems

Insights from a global oncology network

Sharing and analyzing real-world data to generate quality insights that improve outcomes for all people with cancer.


The complexity of precision medicine requires insights from the real world

Syapse offerings for health systems enable:

icon circle checkmark High-level oversight of the practice of precision medicine at your health system
icon circle checkmark Optimization of your clinical trial portfolio for your real-world oncology patient population
icon circle checkmark The application of molecular diagnostics data to clinical care decisions
  • Syapse Executive

    Monitor and optimize the performance of your precision medicine programs through a consultative approach to managing interactive dashboards.

  • Syapse Insights

    The power of real-world data: expand trial enrollment, enable development of exciting new hypotheses, and apply real-world outcomes knowledge to clinical care.

  • Syapse Oncology

    Search molecular results for quick interpretation and action; optimize molecular tumor boards; identify candidates for targeted therapies or genetic counseling with fully integrated clinical and molecular data.

Connectivity with clinical databases, systems, and sources

Precision medicine requires centralized access to patient data that are typically siloed in electronic health records (EHRs), data warehouses, registries, and other systems. Syapse integrates patients’ clinical, pathology, radiology, treatment, lab results, and other information in a central data store to provide a single point of access.

Direct integration with molecular labs to capture structured molecular data

Today, genomic and other molecular test results are typically scanned into EHR systems and stored as unstructured data. Through direct integration with molecular diagnostics labs, Syapse enables healthcare systems to capture molecular profiles as structured data that can be used for decision support in the clinical workflow.

Common data standards across the network

Syapse standardizes and normalizes a robust set of data from multiple systems, allowing health systems to share data with other institutions, including patient demographics, cancer diagnoses, tumor genomics, tumor markers, treatments, and outcomes.


What's new

Toft Group CEO and Founder Robin Toft Joins Syapse Board of Directors

SAN FRANCISCO, Calif., October 28, 2020 — Syapse®, a real-world evidence company accelerating the delivery of precision medicine throu…



For people with cancer — further evidence of worse outcomes due to COVID-19

“Delays in screenings, diagnosis and treatment because of the coronavirus pandemic are likely to result in thousands of “excess” deaths from the disease in coming years.” Ned Sharpless, M.D., director of the National Cancer Institute